Reviews

Quality of life in patients with ischemic heart disease and heart failure

О.J. Zharinov 1, N.B. Іvaniuk 2, О.А. Epanchintseva 2, R.M. Vitovsky 1, B.M. Todurov 2

1 Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
2 Heart Institute Healthcare Ministry of Ukraine, Kyiv, Ukraine

Contemporary information on methods of assessment and predictors of health-related quality of life (HRQOL) in patients with ischemic heart disease (IHD), left ventricular dysfunction (LVD) and heart failure (HF), as well as impact of drugs and revascularization procedures on HRQOL of patients is reviewed in the article. Health-related quality of life is assessed by general and disease-specific questionnaires. The level of HRQOL in patients with IHD and heart failure depends on many factors, such as age, gender, ethnicity, LVD severity, HF NYHA functional class, mental status, etc. But the most powerful determinant of HRQOL is the nature and frequency of symptoms. The ratio of influence on duration and quality of life is an important factor in the evolution of IHD treatment in patients with clinical manifestations of heart failure, including approaches to drug therapy and the choice of optimal revascularization techniques. The results of the conducted controlled studies indicate that the effect of interventions on the HRQOL of patients with IHD and HF may differ depending on type of intervention (endovascular or CABG) and duration of period after it.

Key words: ischemic heart disease, left ventricular dysfunction, revascularization, quality of life.

 

[PDF] [References]